Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of salmeterol, tiotropium, and their combination in acute exacerbation of COPD
IRCT20190123042466N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of salmeterol and tiotropium in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Kashan University of Medical Sciences. Started Apr 2019; status: completed.
02
Drugs
salmeteroltiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20190123042466N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190123042466N1.